Recruiting NCT07334314
Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: olfactory detection by dogs.
- Who it may be relevant to
- Registry conditions: Urothelial Carcinoma. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The aim of this study is to estimate the sensitivity of olfactory detection of urothelial carcinomas of the bladder in urine samples by assistance dogs trained in this practice.
Interventions
- Diagnostic test olfactory detection by dogs
olfactory detection of urothelial carcinoma of the bladder in a urine sample by dogs
Primary outcome measures
- Assess the sensitivity of olfactory detection of urothelial carcinomas of the bladder in urine samples by assistance dogs trained for this purpose [Time frame: Day -60 to Day 0]
Eligibility criteria
Inclusion criteria
- Adult (> 18 years old)
- Subject scheduled for any endourological surgery involving an initial cystoscopy, the most common of which are: transurethral resection of the bladder, transurethral resection of the prostate, internal optical urethrotomy, bladder lithoclast, ureteral stent replacement, ureteroscopy, etc. (non-exhaustive list)
- Subjects for whom a urine sample (for bacteriological or cytological testing) is planned as part of routine practice in the month prior to the procedure
- Subjects affiliated with a health insurance plan or beneficiaries of such a plan
Exclusion criteria
- Absence of signed informed consent / inability to provide the subject with informed information (emergency situations, difficulties in understanding the subject, etc.)
- Patient under guardianship, conservatorship, or judicial protection
- History of cancer other than urothelial bladder carcinoma, unless in complete remission for > 5 years
- Pregnant or breastfeeding women
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
France · 2 centers
- Hôpitaux Civils de Colmar — Colmar
- Hôpitaux Universitaires de Strasbourg — Strasbourg
Identifiers
NCT: NCT07334314 · 9630